278
1. Abdel-Mannan O, D'Argenzio L, Pitt M, et al. Two cases of Guillain-Barré syndrome variants presenting with dysautonomia. Child Neurol Open. 2019;6:2329048X19856778.
2. Agrawal S, Peake D, Whitehouse WP. Management of children with Guillain-Barré syndrome. Arch Dis Child Educ Pract Ed. 2007;92(5):161-168.
3. Al-Hakem H, Doets AY, Stino AM, et al. CSF findings in relation to clinical characteristics, subtype, and disease course in patients with Guillain-Barré syndrome. Neurology. 2023;100(21):e2386-e2397.
4. Barroso E, Tuta-Quintero E, Olivella J, et al. Guillain-Barré syndrome in the paediatric population: consequence of active infection or long COVID? Rev Colomb Reumatol (Engl Ed). 2023;29(4):335-346.
5. Barzegar M, Toopchizadeh V, Maher MHK, et al. Predictive factors for achieving independent walking in children with Guillain-Barré syndrome. Pediatr Res. 2017;82(2):333-338.
6. Basu S, Harrowell L, Singhal N. Paediatric Guillain-Barré syndrome presenting with posterior reversible encephalopathy syndrome. J Paediatr Child Health. 2021;57(10):1689-1690.
7. Bellanti R, Rinaldi S. Guillain-Barré syndrome: a comprehensive review. Eur J Neurol. 2024;31(8):e16365.
8. Buchwald B, de Baets M, Luijckx GJ, Toyka KV. Neonatal Guillain-Barré syndrome: blocking antibodies transmitted from mother to child. Neurology. 1999;53(6):1246-1249.
9. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531-1539.
10. Chiba A, Kusunoki S, Obata H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993;43(9):1911-1917.
11. Delannoy A, Rudant J, Chaignot C, et al. Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008–2013). J Peripher Nerv Syst. 2017;22(1):51-58.
12. DiMario FJ Jr, Edwards C. Autonomic dysfunction in childhood Guillain-Barré syndrome. J Child Neurol. 2012;27(5):581-586.
13. Estrade S, Guiomard C, Fabry V, et al. Prognostic factors for the sequelae and severity of Guillain-Barré syndrome in children. Muscle Nerve. 2019;60(6):716-722.
14. Gupta M, Monjazeb S, Rosser T, Santoro JD, Ahsan N. A case of pediatric Guillain-Barré syndrome after respiratory syncytial virus infection. Pediatr Neurol. 2023;146:129-131.
15. Hu MH, Chen CM, Lin KL, et al. Risk factors of respiratory failure in children with Guillain-Barré syndrome. Pediatr Neonatol. 2012;53(4):295-301.
16. Hughes RA, Wijdicks EF, Barohn R, et al. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003;61(6):736-740.
17. Hughes RA, Wijdicks EF, Benson E, et al. Supportive care for patients with Guillain-Barré syndrome. Arch Neurol. 2005;62(8):1194-1198.
18. Kalita J, Kumar M, Misra UK. Prospective comparison of acute motor axonal neuropathy and acute inflammatory demyelinating polyradiculoneuropathy in 140 children with Guillain-Barré syndrome in India. Muscle Nerve. 2018;57(5):761-766.
19. Korinthenberg R, Trollmann R, Felderhoff-Müser U, et al. Diagnosis and treatment of Guillain-Barré syndrome in childhood and adolescence: an evidence- and consensus-based guideline. Eur J Paediatr Neurol. 2020;25:5-16.
20. Langille MM. Guillain-Barré syndrome in children and adolescents. Adv Pediatr. 2023;70(1):91-103. doi:10.1016/j.yapd.2023.04.001
21. Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671-683.
22. Leonhard SE, van der Eijk AA, Andersen H, et al. An international perspective on preceding infections in Guillain-Barré syndrome: the IGOS-1000 cohort. Neurology. 2022;99(12):e1299-e1313.
23. Lin JJ, Hsia SH, Wang HS, et al. Clinical variants of Guillain-Barré syndrome in children. Pediatr Neurol. 2012;47(2):91-96.
24. Luo H, Hong S, Li M, et al. Risk factors for mechanical ventilation in children with Guillain-Barré syndrome. Muscle Nerve. 2020;62(2):214-219.
25. Maaloul I, Jallouli L, Gargouri R, et al. Guillain-Barré syndrome in a child with multisystem inflammatory syndrome related to COVID-19. Pediatr Infect Dis J. 2022;41(8):e324-e325.
26. Manaud A, Geraudie A, Viguier A, et al. Post-CMV Guillain-Barré syndrome with anti-GM2 antibodies: two cases and a review of the literature. Neuropediatrics. 2022;53(4):235-238.
27. Medscape. Guillain-Barré syndrome. Medscape. Updated September 20, 2023. Accessed September 29, 2025. https://emedicine.medscape.com/article/1180594-overview
28. Mogale KD, Antony JH, Ryan MM. The pharyngeal-cervical-brachial form of Guillain-Barré syndrome in childhood. Pediatr Neurol. 2005;33(4):285-288.
29. Morosini A, Burke C, Emechete B. Polyneuritis cranialis with contrast enhancement of cranial nerves on magnetic resonance imaging. J Paediatr Child Health. 2003;39(1):69-72.
30. Mulkey SB, Glasier CM, El-Nabbout B, et al. Nerve root enhancement on spinal MRI in pediatric Guillain-Barré syndrome. Pediatr Neurol. 2010;43(4):263-267.
31. Nagasawa K, Kuwabara S, Misawa S, et al. Electrophysiological subtypes and prognosis of childhood Guillain-Barré syndrome in Japan. Muscle Nerve. 2006;33(6):766-770.
32. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry. 2001;70(1):50-55.
33. Patone M, Handunnetthi L, Saatci D, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):2144-2153.
34. Pier DB, Hallbergson A, Peters JM. Guillain-Barré syndrome in a child with pain: lessons learned from a late diagnosis. Acta Paediatr. 2010;99(10):1589-1591.
35. Rodriguez-Casero MV, Shield LK, Kornberg AJ. Subacute inflammatory demyelinating polyneuropathy in children. Neurology. 2005;64(10):1786-1789.
36. Roodbol J, de Wit MC, Aarsen FK, Catsman-Berrevoets CE, Jacobs BC. Long-term outcome of Guillain-Barré syndrome in children. J Peripher Nerv Syst. 2014;19(2):121-126.
37. Roodbol J, Korinthenberg R, Venema E, et al. Predicting respiratory failure and outcome in pediatric Guillain-Barré syndrome. Eur J Paediatr Neurol. 2023;44:18-25.
38. Rousseff RT, Khuraibet AJ, Neubauer D. The "child in the barrel syndrome"—severe pharyngeal-cervical-brachial variant of Guillain-Barré syndrome in a toddler. Neuropediatrics. 2008;39(6):354-356.
39. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123-133.
40. Shahrizaila N, Yuki N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry. 2013;84(5):576-583.
41. van den Berg B, Fokke C, Drenthen J, et al. Paraparetic Guillain-Barré syndrome. Neurology. 2014;82(21):1984-1989.
42. Wakerley BR, Yuki N. Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barré syndrome. J Neurol. 2015;262(9):2001-2007.
43. Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717-727.
44. Winer JB. Bickerstaff's encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry. 2001;71(4):433-435.
45. Yikilmaz A, Doganay S, Gumus H, et al. Magnetic resonance imaging of childhood Guillain-Barré syndrome. Childs Nerv Syst. 2010;26(8):1103-1108.
46. Yiu E, Yum SW. Guillain-Barré syndrome in children: epidemiology, clinical features, and diagnosis. UpToDate. Updated July 19, 2024. Accessed September 27, 2025. https://www.uptodate.com/contents/guillain-barre-syndrome-in-children-epidemiology-clinical-features-and-diagnosis
47. Yiu E, Yum SW. Guillain-Barré syndrome in children: treatment and prognosis. UpToDate. Updated September 23, 2025. Accessed September 29, 2025. https://www.uptodate.com/contents/guillain-barre-syndrome-in-children-treatment-and-prognosis
48. Zuccoli G, Panigrahy A, Bailey A, Fitz C. Redefining the Guillain-Barré spectrum in children: neuroimaging findings of cranial nerve involvement. AJNR Am J Neuroradiol. 2011;32(4):639-642.